The Immunology Podcast

Dr. Camila Coelho is a Principal Investigator at the Icahn School of Medicine at Mount Sinai, where her lab studies emerging pathogens. She talks about her lab's work on mpox and other viruses, her approach to mentorship, and how her MBA education helps her in science.

Professor Matteo Iannacone is Director of the Division of Immunology, Transplantation and Infectious Diseases, Professor of Pathology, and Head of the Dynamics of Immune Responses laboratory at Vita-Salute San Raffaele University. His work centers on understanding the generation of dysfunctional adaptive immune cells in chronic hepatitis B virus infection and developing new strategies to reprogram them into functional cells endowed with potent antiviral activity.

Dr. Harikesh Wong is an Assistant Professor at the Ragon Institute and MIT, where his lab studies the design principles of the immune system. He talks about how Tregs constrain conventional T cell responses during infection, and advanced fluorescence microscopy techniques to study immune responses.

Dr. Eric Vivier is a Professor of Immunology at Aix-Marseille Université and the Centre d’Immunologie de Marseille-Luminie. He is also a member of the expert panel of the European Research Council as well as the French Society of Immunology. In this special episode recorded at the IUIS 2025 Congress in Vienna, Dr. Vivier highlights the critical importance of investing in science, explores the responsibility of governments and other organizations in funding research, and reflects on the role science plays in society.

In August 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria. We chat with delegates about their research and impressions of the meeting. They discuss the most memorable research presented and their experiences in Austria.

Dr. Zwi Berneman is Emeritus Professor of Hematology at the University of Antwerp, and previously Head of the Division of Hematology at the Antwerp University Hospital. His basic and clinical research is focused on vaccination with immunogenic dendritic cells in cancer and with tolerogenic dendritic cells in multiple sclerosis. He talks about the history and development of dendritic cell vaccines and the work needed to make them more widely available to patients.

In 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria, and recorded daily episodes discussing highlights of the conference. Here is the final of five special episodes from the meeting, in which Brenda and Jason discuss sessions on AI applications and CAR T therapy progress.

In 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria, and recorded daily episodes discussing highlights of the conference. Here is the fourth of five special episodes from the meeting, in which Jason and Brenda discuss sessions on cancer immunotherapy and neuroimmunology.

In 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria, and recorded daily episodes discussing highlights of the conference. Here is the third of five special episodes from the meeting. Brenda and Jason discuss sessions on CD4+ T cells in Hepatitis B infections and how amoebas make their way to the brain. They also cover research on the effects of antibiotics on immunotherapy, and what we can learn about allergies by comparing pet shop and lab mice.

In 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria, and recorded daily episodes discussing highlights of the conference. Here is the second of five special episodes from the meeting. Brenda and Jason cover research on Lynch syndrome, dendritic cells, and the epigenome of regulatory T cells.

In 2025, we attended the 19th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Vienna, Austria, and recorded daily episodes discussing highlights of the conference. Here is the first of five special episodes from the meeting. Brenda and Jason discuss sessions on colon cancer organoids and stable induced regulatory T cells. They also cover presentations from the IUIS Rising Star Awardees and Dr. Yasmine Belkaid's talk on maternal physiology.

Dr. Daniel Goodman is an Assistant Professor at the University of Pennsylvania, where his lab researches high-throughput approaches to engineer the immune system. He talks about new technologies for immune cell engineering, and methods for screening and developing CAR T therapies.

Dr. Tamara Tilburgs is an Assistant Professor in the University of Cincinnati Department of Pediatrics, where her research focuses on immune tolerance during pregnancy. She talks about the immune paradox in trophoblast cells and how placental inflammation can lead to pregnancy complications. She also discusses CD8+ T cell responses at the maternal-fetal interface.

Dr. Johnathan Canton is an Assistant Professor at the University of Calgary, where his lab uses advanced microscopy techniques to study dendritic cells, macrophages, and innate immunity. He talks about his career journey from studying tropical parasites to investigating phagocytes. He also discusses using advanced microscopy techniques, studying the mechanisms of dendritic cell cross-presentation, and running a farm in Belize.

Dr. Mahima Swamy is a Program Leader at the University of Dundee, where her lab studies immune homeostasis in the intestinal epithelium. She talks about intestinal intraepithelial lymphocytes and the role of LRRK2 in Parkinson’s and Crohn’s disease.

Dr. Rizwan Romee is a Oncologist at the Dana-Farber Cancer Institute and Associate Professor at Harvard Medical School, where his research focuses on genetically manipulating NK cells to enhance their anti-tumor function. He talks about advances and challenges in engineering NK cells for cancer therapy. He also discusses using E. coli to deliver immune-activating cytokines to tumors.

Dr. Arthur Mortha is an Associate Professor at the University of Toronto. His research focuses on innate lymphoid cells and their interactions with microbes. He talks about ILCs and how the gut microbiome can affect respiratory disease.

In May 2025, we attended IMMUNOLOGY2025™, the annual meeting of the American Association of Immunologists, in Honolulu. We chat with delegates about their research and impressions of the meeting. They discuss their reasons for attending, the most memorable research, and their experiences in Hawaiʻi.

This special episode was recorded in front of a live audience at IMMUNOLOGY2025™ in Honolulu. In this conversation, hosted by Dr. Nicole Quinn, Brenda and Jason share what they've learned from recording over 100 episodes of the Immunology Podcast. They talk about how the field has evolved during the past four years, the importance of making science and scientists accessible, and predictions for emerging areas of research.